Clinical Trials Browser

Phase 3 × Breast Neoplasms × netupitant, palosentron drug combination × Clear all

NCT03367572 2025-09-25

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

Phase 3 Completed

1,363 enrolled 20 charts

Breast Neoplasms